Dr. Martens (LON:DOCS) Trading Down 9.6% – Here’s What Happened

by · The Cerbat Gem

Dr. Martens plc (LON:DOCS – Get Free Report) dropped 9.6% on Thursday . The company traded as low as GBX 72.30 and last traded at GBX 73.80. Approximately 4,733,644 shares were traded during mid-day trading, an increase of 115% from the average daily volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.

Analysts Set New Price Targets

Separately, Peel Hunt reissued a “buy” rating on shares of Dr. Martens in a research note on Thursday. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, Dr. Martens currently has a consensus rating of “Hold” and a consensus target price of GBX 6,000.

Check Out Our Latest Report on Dr. Martens

Dr. Martens Price Performance

The stock has a market capitalization of £707.84 million, a price-to-earnings ratio of 146.50, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27. The stock has a fifty day moving average of GBX 89.93 and a 200-day moving average of GBX 80.44.

Dr. Martens (LON:DOCS – Get Free Report) last released its quarterly earnings data on Thursday, November 20th. The company reported GBX (0.90) earnings per share for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. On average, equities research analysts predict that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Insider Buying and Selling at Dr. Martens

In other news, insider Ije Nwokori sold 298,675 shares of Dr. Martens stock in a transaction dated Wednesday, October 15th. The stock was sold at an average price of GBX 90, for a total transaction of £268,807.50. Also, insider Giles Wilson bought 105,838 shares of Dr. Martens stock in a transaction dated Monday, September 1st. The stock was purchased at an average cost of GBX 91 per share, with a total value of £96,312.58. In the last 90 days, insiders acquired 136,960 shares of company stock valued at $12,460,163 and sold 434,460 shares valued at $39,131,400. Corporate insiders own 2.80% of the company’s stock.

Dr. Martens Company Profile

(Get Free Report)

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.

See Also